RNAM - Avidity Biosciences Inc
0 0%
Share volume: 0
Last Updated:
Pharmaceutical Products/Pharmaceutical Preparations:
3.19%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
View ratios
| Fiscal Date | 12-31-2025 | |
|---|---|---|
| Fiscal Quarter | Q4 2025 | |
| Report Date | 02-23-2026 | |
| Total revenue | 860.000 K | |
| Cost of revenue | 0.000 | |
| Gross profit | 860.000 K | |
| Operating expenses | 255.338 M | |
| Selling general and admin | 88.742 M | |
| Research and development | 166.596 M | |
| Total expenses | 255.338 M | |
| Operating income | -254.478 M | |
| Ebit | -254.955 M | |
| Pretax income | -237.101 M | |
| Income tax | 0.000 | |
| Net income basic | 0.000 | |
| Net income | -237.101 M | |